Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)

被引：66
|
作者：
Demeter, LM
Shafer, RW
Meehan, PM
Holden-Wiltse, J
Fischl, MA
Freimuth, WW
Para, MF
Reichman, RC
机构：
[1] Univ Rochester, Infect Dis Unit, Sch Med & Dent, Rochester, NY 14642 USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Univ Miami, Miami, FL 33152 USA
[5] Pharmacia & Upjohn Inc, Kalamazoo, MI 49001 USA
[6] Ohio State Univ, Columbus, OH 43210 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 03期
关键词：
D O I：
10.1128/AAC.44.3.794-797.2000
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The development of human immunodeficiency virus type 1 resistance to delavirdine (DLV) was studied in subjects receiving DLV monotherapy. Phenotypic resistance developed in 28 of 30 subjects within 8 weeks. K103N and Y181C, which confer nonnucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance, were the predominant reverse transcriptase mutations. P236L, which confers DLV resistance but hypersensitivity to other NNRTIs, developed in <10% of isolates.
引用
收藏
页码：794 / 797
页数：4
相关论文
共 50 条
  • [31] Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations
    Monno, L
    Appice, A
    Cavaliere, R
    Scarabaggio, T
    Angarano, G
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 568 - 570
  • [32] Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients
    Kim, EY
    Winters, MA
    Kagan, RM
    Merigan, TC
    JOURNAL OF VIROLOGY, 2001, 75 (22) : 11227 - 11233
  • [33] THE STRUCTURE OF UNLIGANDED REVERSE-TRANSCRIPTASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    RODGERS, DW
    GAMBLIN, SJ
    HARRIS, BA
    RAY, S
    CULP, JS
    HELLMIG, B
    WOOLF, DJ
    DEBOUCK, C
    HARRISON, SC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 1222 - 1226
  • [34] Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals
    Brindeiro, R
    Vanderborght, B
    Caride, E
    Correa, L
    Oravec, RM
    Berro, O
    Stuyver, L
    Tanuri, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1674 - 1680
  • [35] Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production
    Chiang, Chien-Cheng
    Wang, Shiu-Mei
    Tseng, Ying-Tzu
    Huang, Kuo-Jung
    Wang, Chin-Tien
    VIROLOGY, 2009, 383 (02) : 261 - 270
  • [36] Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
    Julias, JG
    Boyer, PL
    McWilliams, MJ
    Alvord, WG
    Hughes, SH
    VIROLOGY, 2004, 322 (01) : 13 - 21
  • [37] Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates
    Whitcomb, JM
    Parkin, NT
    Chappey, C
    Hellmann, NS
    Petropoulos, CJ
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07): : 992 - 1000
  • [38] A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors
    Zhang, Zhijun
    Xu, Wen
    Koh, Yung-Hyo
    Shim, Jae Hoon
    Girardet, Jean-Luc
    Yeh, Li-Tain
    Hamatake, Robert K.
    Hong, Zhi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 429 - 437
  • [39] Intra patient evolution of Human Immunodeficiency Virus Type 1 protease and reverse transcriptase in antiretroviral naive patients
    Shanmugasundaram, Uma
    Nagalingeswaran, Kumarasamy
    Murugavel, Kailapuri G.
    Shanmugam, Saravanan
    Madhavan, Vidya
    Solomon, Sunil S.
    Solomon, Suniti
    Mayer, Kenneth H.
    Pachamuthu, Balakrishnan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 185 - 185
  • [40] Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase
    Zhu, K
    Dobard, C
    Chow, SA
    JOURNAL OF VIROLOGY, 2004, 78 (10) : 5045 - 5055
12345